Rigel Pharmaceuticals

  www.rigel.com
  www.rigel.com
Work in HR? Unlock Free Profile

Rigel Pharmaceuticals Photos

Lobby
Rigel Building
Cafeteria

+ Add Photo

Rigel Pharmaceuticals Reviews

5 Reviews
3.1
5 Reviews
Rating Trends

Recommend to a friend
Approve of CEO
(no image)
James M. Gower
3 Ratings
  1.  

    Nice place to work

    • Comp & Benefits
    • Work/Life Balance
    • Senior Management
    • Culture & Values
    Former Employee - Anonymous
    Former Employee - Anonymous

    I worked at Rigel Pharmaceuticals

    Pros

    Nice lab and friendly environment

    Cons

    Just needed to finish work on time

    Advice to ManagementAdvice

    Nothing

    Recommends
    Neutral Outlook
    No opinion of CEO

Rigel Pharmaceuticals Interviews

Interview Experience

Interview Experience

0%
100%
0%

Getting an Interview

Getting an Interview

100%

Interview Difficulty

3.0
Average

Interview Difficulty

Hard

Average

Easy
  1.  

    Pharmaceuticals Interview

    Anonymous Employee
    Anonymous Employee
    Application Details

    I applied online. The process took 2 days - interviewed at Rigel Pharmaceuticals in June 2010.

    Interview Details

    Very organized HR department.

    Interview Questions
    No Offer
    Neutral Experience
    Average Interview

Rigel Pharmaceuticals Awards & Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Additional Info

Unlock Profile
Website www.rigel.com
Headquarters South San Francisco, CA
Size 150 to 499 Employees
Founded 1996
Type Company - Public (RIGL)
Industry Biotech & Pharmaceuticals
Revenue $5 to $10 million (USD) per year

When immune systems attack, Rigel Pharmaceuticals wants to be there. The drug discovery and development firm focuses its research and development efforts on inflammatory/autoimmune, muscle, and metabolic diseases. Drugs in development include candidates for treating rheumatoid arthritis, psoriasis, muscle wasting, multiple sclerosis, and transplant rejection. Rigel prefers to collaborate with larger pharmaceutical companies in the development of its drug candidates. Rigel Pharmaceuticals went public through a $140 million IPO in 2011. The company intends to use the funds... More

Worked for Rigel Pharmaceuticals? Contribute to the Community!